Mbm Wealth Consultants, LLC Amgen Inc Transaction History

Mbm Wealth Consultants, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $13,243 - $14,935	-59 Reduced 51.3%	56 $13,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $74,434 - $88,638	-344 Reduced 74.95%	115 $26,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $17,598 - $19,571	-75 Reduced 14.04%	459 $117,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $37,842 - $48,640	200 Added 59.88%	534 $129,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $59,585 - $69,555	334 New	334 $65,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mbm Wealth Consultants, LLC, based on Form 13F filings with the SEC.

Stay updated on Mbm Wealth Consultants, LLC with notifications on news.